SETD2 and neoplasm: SETD2-deficient tumors were particularly sensitive to rapamycin treatment, which had a similar suppressive effect on tumor growth as phenformin which inhibits both mitochondrial complex I and mTORC1 signaling (Fig. 4B, C).